<DOC>
	<DOCNO>NCT02763254</DOCNO>
	<brief_summary>To investigate efficacy autologous Epstein-barr virus ( EBV ) -specific T cell treatment EBV positive Diffuse Large B Cell Lymphoma ( DLBCL ) , Hodgkin Lymphoma ( HL ) Post-transplant Lymphoproliferative Disease ( PTLD ) fail first line treatment .</brief_summary>
	<brief_title>Cellular Immunotherapy Viral Induced Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Lymphoproliferative Disorders</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<criteria>1 . The study include three primary cohort , follow EBV+ disease : Cohort A DLBCL , 1 ) first subsequent relapse , eligible autologous transplantation follow salvage therapy OR 2 ) relapse follow autologous transplantation . Cohort B HL , brentuximab vedotin ( BV ) treatment failure unable tolerate BV . Cohort C PTLD , rituximab treatment failure . 2 . Presence active lymphoma active PTLD , base imaging perform within previous 3 month . 3 . Tumor positive EBV encode RNA ( EBER ) base report certify laboratory . 4 . Absolute lymphocyte count ( ALC ) &gt; 500/µL 5 . Male female ≥ 12 year age 6 . Weight ≥ 35 kg 7 . Eastern Cooperative Oncology Group ( ECOG ) performance score 02 , inclusively Lansky score ≥ 60 , age appropriate 8 . Able understand comply requirement study provide write informed consent age appropriate assent pediatric patient . 1 . Known central nervous system ( CNS ) lymphoma 2 . Primary refractory HL DLBCL 3 . Bulky disease 4 . Relapse progression follow previous autologous EBV specific T cell treatment . 5 . Use systemic corticosteroid within 10 day prior obtain 200 mL start material . 6 . Positive HIV , hepatitis B , hepatitis C , syphilis human T cell leukemia virus ( HTLV ) . 7 . Patient pregnant lactate 8 . Systemic fungal , bacterial , viral infection control 9 . Prior allogeneic hematopoietic stem cell transplantation ( allo HSCT ) 10 . Known history primary immunodeficiency</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Epstein-Barr Virus ( EBV )</keyword>
</DOC>